Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,488 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting.
Nam Y, Kim HC, Kim YC, Jang SH, Lee KY, Lee SY, Lee SH, Lee SY, Yoon SH, Ryu JS, Jang TW, Chang YS, Kim SJ, Park CK, Lee JE, Jung CY, Choi CM. Nam Y, et al. Among authors: lee sh, lee sy, lee je, lee ky. Thorac Cancer. 2021 Mar;12(6):890-898. doi: 10.1111/1759-7714.13857. Epub 2021 Feb 2. Thorac Cancer. 2021. PMID: 33529490 Free PMC article.
Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea.
Jeon DS, Park CK, Kim SJ, Park CK, Chang YS, Jung CY, Lee SY, Lee SY, Ryu JS, Lee JE, Lee KY, Jang TW, Jang SH, Yoon SH, Lee SH, Choi CM, Kim HR, Kim YJ. Jeon DS, et al. Among authors: lee sh, lee sy, lee je, lee ky. Thorac Cancer. 2024 Feb;15(6):448-457. doi: 10.1111/1759-7714.15213. Epub 2024 Jan 3. Thorac Cancer. 2024. PMID: 38171544 Free PMC article.
Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South Korea.
Kim T, Jang TW, Choi CM, Kim MH, Lee SY, Park CK, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH. Kim T, et al. Among authors: lee sh, lee sy, lee je, lee ky. Cancer Med. 2021 Sep;10(17):5809-5822. doi: 10.1002/cam4.4127. Epub 2021 Jul 13. Cancer Med. 2021. PMID: 34258882 Free PMC article.
Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer.
Lee JH, Kim EY, Park CK, Lee SY, Lee MK, Yoon SH, Lee JE, Lee SH, Kim SJ, Lee SY, Lim JH, Jang TW, Jang SH, Lee KY, Lee SH, Yang SH, Park DW, Park CK, Kang HS, Yeo CD, Choi CM, Lee JC. Lee JH, et al. Among authors: lee sh, lee sy, lee jc, lee je, lee mk, lee ky. Cancer Res Treat. 2023 Jan;55(1):112-122. doi: 10.4143/crt.2022.381. Epub 2022 Jul 19. Cancer Res Treat. 2023. PMID: 36049499 Free PMC article.
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors.
Kim J, Jang TW, Choi CM, Kim MH, Lee SY, Park CK, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH. Kim J, et al. Among authors: lee sh, lee sy, lee je, lee ky. Transl Lung Cancer Res. 2023 Jun 30;12(6):1197-1209. doi: 10.21037/tlcr-22-832. Epub 2023 Jun 12. Transl Lung Cancer Res. 2023. PMID: 37425421 Free PMC article.
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study.
Park JE, Hong KS, Choi SH, Lee SY, Shin KC, Jang JG, Kwon YS, Park SH, Choi KJ, Jung CY, Eom JS, Kim S, Seol HY, Kim J, Kim I, Park JH, Kim TH, Ahn JH. Park JE, et al. Among authors: lee sy. Clin Lung Cancer. 2024 Jun;25(4):354-364. doi: 10.1016/j.cllc.2024.02.006. Epub 2024 Feb 17. Clin Lung Cancer. 2024. PMID: 38503590
13,488 results
You have reached the last available page of results. Please see the User Guide for more information.